“The advances in technology have allowed us to go from one step to another. Likewise, we are looking to the future and the not-so-distant future when gene manipulation and gene editing will be part of the therapy.”
Stuart H. Orkin is the David G. Nathan Distinguished Professor of Pediatrics at Harvard Medical School.
Orkin received his MD in 1972 from Harvard Medical School, followed by postdoctoral research at the National Institutes of Health and clinical training in pediatrics and hematology-oncology at Children’s Hospital Boston and DFCI, where he joined the faculty in 1978. Dr. Orkin is a Howard Hughes Medical Institute Investigator and was elected to the 2019-2020 Council of the National Academy of Medicine. Over the past decade, his laboratory has defined critical nuclear regulators of hematopoiesis.